Availability: In Stock

Ankylosing Spondylitis

SKU: 9780199752928

Original price was: $22.99.Current price is: $5.75.

Access Ankylosing Spondylitis Now. Discount up to 90%

Categories: ,

Additional information

Full Title

Ankylosing Spondylitis

Author(s)

Michael H. Weisman

Edition
ISBN

9780199752928, 9780195399103, 9780199753154

Publisher

Oxford University Press

Format

PDF and EPUB

Description

Ankylosing Spondylitis is an inflammatory arthritis that affects the spine and sacroiliac joints as well as other parts of the body, and that can eventually lead, in some patients, to complete fusion of the vertebrae and total rigidity. AS is not a rare health problem, but is in fact found in almost one percent of the US population, typically strikes young people and young families, and in its various forms is probably more common than rheumatoid arthritis. In this invaluable guide, Dr. Michael H. Weisman, one of America’s leading authorities on AS, provides a down-to-earth, crystal-clear guide that is ideal for patients and their family. Dr. Weisman explains what AS is, discusses the genetic background to the disease (including the genes that researchers think may predispose some people to AS), explains how to diagnose the disease early and possibly prevent the later development of debilitating rigidity, the use of MRI for early detection, and much more. The book outlines which medications (such as TNF inhibitors) seem the most promising right now, the various drug side effects, the value of physical therapy, other treatment approaches, and whether surgery can be used to manage the complications of the disease. AS can lead to severe disability, but even those who have a milder form will experience painful “flares” alternating with periods of remission. Since it is a progressive disease in many patients, it is very important to reach patients as early as possible. This book will arm patients with the vital information they need to combat the disease. Laurie M. Savage, the Executive Director of the Spondylitis Association of America (SSA), the main patient support group world-wide, has written a foreword to the book. In addition, SSA will endorse the book and their logo will appear on the cover.

Availability: In Stock

Ankylosing Spondylitis

SKU: 9780190451301

Original price was: $31.99.Current price is: $9.60.

Access Ankylosing Spondylitis Now. Discount up to 90%

Categories: ,

Additional information

Full Title

Ankylosing Spondylitis

Author(s)

Muhammad Asim Khan

Edition
ISBN

9780190451301, 9780195368079, 9780199709755

Publisher

Oxford University Press

Format

PDF and EPUB

Description

Ankylosing Spondylitis (AS) and related diseases called spondyloarthropathies (SpA) are the second most common form of chronic inflammatory arthritis after Rheumatoid Arthritis (RA). Unfortunately, most patients with AS and SpA are either never diagnosed, or they are inadequately treated. The current mean delay in the diagnosis of AS ranges from 5 to 10 years, and the presenting clinical manifestations of these diseases are wide-ranging and heterogeneous, and thus a variety of health care professionals see AS and SpA patients, from primary care physicians to rheumatologists and other medical and surgical specialists. With the availability of newer, highly effective treatments and better methods of musculoskeletal imaging, such as the MRI, there is an urgent need to improve early diagnosis and reduce any inappropriate delay in obtaining effective treatment. Earlier diagnosis and treatment can mitigate the severity of the disease, and make a meaningful difference for patient care and quality of life. The proposed book is designed for specialists and generalists alike, and is intenteded to expedite accurate diagnosis and initiation of appropriate treatment in order to alleviate unnecessary suffering.Part of the new Oxford American Rheumatology Library series, this pocket-sized book provides practical, evidence-based information for clinicians to aid diagnosis, treatment, and follow-up care for patients with AS and SpA. The book provides pointers to early diagnosis, prognosis, clinical manifestations, socioeconomic aspects, and disease management. It also provides comprehensive coverage of current treatment options, including the latest biologics, as well as non-drug therapies.